Myosteatosis, which is excessive fat infiltration in the skeletal muscle, is now considered a
distinct disease from sarcopenia. Advances in imaging technique have made muscle …

Skeletal muscle and bone share common embryological origins from mesodermal cell
populations and also display common growth trajectories early in life. Moreover, muscle and …

Objectives To assess the impact of sarcopenia and alterations in body composition
parameters (BCPs) on survival after surgery for oesophageal and gastro-oesophageal …

Background Physical exercise and nutritional treatment are promising measures to prevent
muscle wasting that is frequently observed in advanced-stage cancer patients. However …

Androgen deprivation therapy continues to be widely used for the treatment of prostate
cancer despite the appearance of new‐generation androgen‐receptor targeting drugs after …

Progressive skeletal muscle wasting in cancer cachexia involves a process of dysregulated
protein synthesis and breakdown. This catabolism may be the result of mal‐nutrition, and an …

Background Body composition may influence clinical outcomes of certain chemotherapeutic
agents. We examined the prognostic significance of skeletal muscle mass and adipose …

Objectives To examine whether it is more efficacious to commence exercise medicine in
men with prostate cancer at the onset of androgen‐deprivation therapy (ADT) rather than …

Exercise oncology is rapidly evolving, with impressive possibilities that may directly improve
patient outcomes in advanced prostate cancer. Research must focus on translating …

Background Diet and exercise may be associated with quality of life and survival in men with
prostate cancer. Objective This study aimed to determine the feasibility and acceptability of a …